Solid Dosage
With our comprehensive portfolio of oral solid dosage solutions, we can supply full process lines with containment — from powder to coated tablet — including interfaces for powders, APIs and excipient dispensing, dry milling, powder collection, blending and more.
Steroids, endogenous hormones such as estrogen and testosterone and the adrenal cortex hormones, cortisol and aldosterone, play a key role in metabolic processes and have a number of pharmaceutical applications, including contraception, hormone therapy, antirheumatic, antiarthritic and bodybuilding preparations.
Predominantly used in global hormone replacement therapy, the three major segments comprise estrogen, growth and thyroid hormone, and testosterone replacement therapy. A major market driver is the increased awareness of postmenopausal hazards amongst women; others include an aging population, innovative drug delivery systems and the pharmerging economies.
Occupational steroid exposure can occur when the active ingredients are inhaled, ingested or absorbed through exposed skin. Although exposure can occur at any point in the production process, the greatest potential for worker exposure during steroid/hormonal drug production occurs during weighing, material transfer, equipment loading or milling.
Nevertheless, unit operations such as blending, granulation, drying, tablet compression and coating can also present hazards. It can even occur in the packaging area, during sampling and quality control, the testing of raw materials, intermediates and finished products, and during maintenance and cleaning.
Manufacturers have the responsibility to protect their operators, particularly those working with potent and toxic compounds, and set defined areas or controls necessary to eliminate the risk of product cross-contamination on a case-by-case basis.
GEA can help you to achieve these goals. From facility design and layout, manufacturing process controls (including adherence to standard operating procedures) and environmental control systems (HVAC) to extraction systems, industrial hygiene solutions and fully integrated, end-to-end containment solutions. We can advise and assist you to determine what level of containment is required where and when, optimizing the manufacturing process and making it efficient, safe and cost-effective.
26 の 4 を表示する
GEA の革新的な CIP コンセプトは、包括的な最高規格を満たしています。当社のエキスパートは、プロセスのあらゆる時点で、製品の安全性を保証しています。どのアップグレードも、現場の個々の条件および顧客の要件に適合し、顕著な節約を実現します。
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
地球温暖化の影響は世界中でますます明らかになっています。あらゆる地域の町や都市が同じ課題に直面しています。それは、信頼性が高く、手頃な価格で、持続可能な供給源からの熱を地域社会に供給することです。GEAは、この分野の専門家であるGEA Heating & Refrigeration TechnologiesのヒートポンプマネージャーであるKenneth Hoffmannに、地球温暖化への迅速な対応について話を聞きました。
酪農家のトムの目に留まったもの。従来の製品デモの代わりに、GEAはAR(拡張現実)によるイノベーションを紹介しました。これはGEAのインタラクティブなデジタル酪農場始まりにすぎません。